Introduction
Chest pain is the most common initial manifestation of coronary artery disease (CAD). 1 Therefore, rapid access chest pain clinics have been established for prompt assessment and diagnosis of patients with suspected angina with no prior history of CAD. 2 Exercise electrocardiography (ECG) is widely used in the UK for the initial assessment of patients in rapid access chest pain clinics once the diagnosis of acute myocardial infarction (AMI) has been excluded. It is used in 59% of chest pain assessment clinics in the UK 3 and 76% of patients in the Euro heart survey. 4 However, the incremental value of exercise ECG over clinical assessment for risk assessment of these cohorts of patients is of dubious value. 5 Stress echocardiography (SE) (dobutamine and exercise) is an alternative technique now routinely used for the risk stratification of patients with suspected CAD due to its feasibility, safety, and prognostic accuracy 6 -8 and is recommended by the European Association of Echocardiography (EAE). 9, 10 Numerous studies have shown its prognostic value in cohorts of patients with known and suspected CAD and in patients without a history of CAD. 11 -16 However, to our knowledge, there have been no studies that specifically assessed the incremental value of SE as the first line of investigation, beyond clinical assessment and stress ECG in consecutive patients with new-onset suspected angina without an established diagnosis of CAD. We therefore sought to assess the incremental prognostic value of SE (both exercise and dobutamine) for the prediction of short-to mediumterm hard cardiac events in such patients.
Methods
Patients who had undergone SE from June 2005 to December 2007 were identified from our SE database. Patients who were assessed for the first time with suspected angina and no prior history of CAD were selected. Patients were sent consent forms inviting them to participate and event data were collected by questionnaires sent. Additional telephone follow-up or hospital record reviews were performed where appropriate. Ethical approval was obtained from the local Ethics Committee and the study complied with the Declaration of Helsinki.
Clinical risk stratification
Framingham's risk score (10-year mortality) was calculated for all patients based on their gender, smoking status, presence of left ventricular hypertrophy (LVH), presence of diabetes mellitus, blood pressure, and cholesterol level. A percentage of risk was hence obtained. A score of up to ,11% was considered low risk, 11 to ,21% medium risk, and .21% high risk for events.
Twelve-lead electrocardiogram
An abnormal 12-lead ECG at rest and at stress was defined as ≥2 mm ST depression or elevation 80 mm from the J point in two or more contiguous leads, left bundle branch block (LBBB) or right bundle branch block with QRS duration of more than 120 ms, the presence of atrial fibrillation/flutter, and T-wave inversion in two or more contiguous leads. A prognostically significant ischaemic 12-lead ECG at stress and at rest stress was defined as ≥2 mm ST depression or elevation 80 mm from the J point in two or more contiguous leads or the development of T-wave inversion in two or more contiguous leads. Duke's treadmill score taking into account patient's symptoms, extent of ST shift during exercise, and total exercise time was calculated.
Stress echocardiography
Patients underwent either exercise (treadmill) or pharmacological stress testing with dobutamine, at the discretion of the attending cardiologist, and our standard protocol applied. A two-dimensional echocardiogram was performed in the left lateral decubitus position using harmonic imaging. Digitalized images of the LV were obtained in the apical four-, two-, and three-chamber views and in the parasternal long-and short-axis views.
For exercise echocardiography, standard symptom-limited treadmill exercise was performed and images were acquired immediately after peak exercise, within 60 -90 s. Early post-exercise images with the best endocardial definition were selected and displayed alongside the corresponding baseline images.
Where patients were deemed unsuitable for exercise, dobutamine was infused via an intravenous cannula inserted peripherally. The dose of dobutamine was increased every 3 min starting at 10 mg/kg/ min to 20, 30, and 40 mg/kg/min. If endpoints were not achieved, atropine was added to the continuing 40 mg/kg/min dobutamine infusion in four divided doses of 0.3 mg up to a maximum of 1.2 mg.
Endpoints were chest pain or the achievement of 85% of agepredicted target heart rate or the development of ischaemia (wall thickening abnormality), the achievement of peak dose of dobutamine and 1.2 mg of atropine, or the occurrence of intolerable side effects. Stress images were then acquired and assessed in the same way as in the exercise stress protocol. Where images were suboptimal with poor endocardial border definition, an intravenous contrast agent was administered (Optison, Amersham Health, UK, or Sonovue, Bracco Diagnostics, Geneva, Switzerland) through the peripheral cannula followed by a flush with 0.9% NaCl solution.
Interpretation of echo and electrocardiogram
Online digital images were interpreted qualitatively by an experienced reader. The 17-segment LV model was used and a four-point scale used to assess wall thickening at rest and at stress (1, normal; 2, reduced wall thickening; 3, absence of wall thickening; and 4, dyskinetic motion). 17 Inducible ischaemia was defined as new or worsening wall thickening abnormality during stress in two or more contiguous LV segments. Wall thickening score index at rest (RWTSI) and at stress (SWTSI) was calculated by dividing the total wall thickening score by the number of segments analysed. The ischaemic burden of the LV was then calculated by subtracting the peak WTSI from rest. Rest and stress ECG were interpreted by an experienced reader. Criteria for an abnormal ECG are previously described.
Coronary angiography
The decision to proceed to coronary angiography was taken by the attending cardiologist in consideration with the result of the SE. Standard techniques were used by the physician performing the coronary angiogram utilizing a visual qualitative scoring system for image analysis with CAD defined as .50% luminal diameter narrowing in one or more epicardial arteries or their major branches. 18 The decision regarding the need for and type of revascularization was taken by the attending cardiologist.
Follow-up
Patients were sent questionnaires detailing their medical history. A review of medical notes was performed to gain more insight into documented cardiac events. Telephone follow-up was performed where appropriate.
Statistical analysis
Continuous variables are expressed as mean + SD and categorical variables expressed as percentages. Cox's proportional hazard analysis was utilized to assess the impact of the various clinical (hypertension defined as systolic blood pressure ≥140 mmHg and diastolic blood pressure ≥90 mmHg or use of antihypertensive medication; diabetes mellitus defined as fasting blood glucose .7.0 mmol/L or requirement for insulin or orally administered hypoglycaemic agents; hypercholesterolaemia defined as total cholesterol ≥5.0 mmol/L or use of a cholesterol-lowering agent; and smoker, past or present), stress ECG (resting and stress: heart rate, systolic and diastolic blood pressure, and ST-T changes as well as Duke's score, total exercise time, and Mets), and SE parameters (RWTSI, SWTSI, and ischaemic burden) for the prediction of cardiac mortality and non-fatal AMI.
The prognostically significant variables in the univariable analysis (P , 0.1) were then entered into a multivariable model to determine the independent predictors for hard cardiac events. A global x 2 model was used to determine the incremental value of one test over another performed in a hierarchal manner. The Kaplan -Meier survival curves were constructed showing the survival of patients with and without an ischaemic burden and the survival of different degrees of ischaemic burden. The log-rank test was used to compare the event rates in the two groups. Statistical analysis was performed using SPSS version 14.0 (SPSS Inc., Chicago, IL, USA).
Results
Follow-up data were obtained in 547 (91%) of the 600 patients. Fifty-three patients were either lost to follow-up or did not consent to participation. Table 1 details the characteristics of the 547 patients. The mean age was 68 years and majority complained of typical chest pain. The majority of the patients (64%) belonged to the medium-risk group according to the Framingham risk score.
Resting ECG was normal in .80% of the patients. Stress ECG suggestive of ischaemia was seen in 136 (25%) patients ( Table 2) . None of the patients had resting wall motion abnormality. SE demonstrated ischaemia in 22% of the patients ( Table 2) .
Contrast was administered in 136 of 461 (30%) patients who had documentation of its usage.
Follow-up results
During a median follow-up period of 28 months, there were 35 (6.4%) hard events (5 cardiac deaths and 30 non-fatal AMI). Patients with events had a higher incidence of hyperlipidaemia, and their Framingham risk score was higher. More patients with events demonstrated stress-induced LV dysfunction and ischaemic burden compared with those without events ( Table 3 ). In the exercise echo cohort [n ¼ 347 (63%)], there were 20 (3.6%) hard cardiac events (1 death and 19 AMI).
Coronary arteriography and revascularization outcome
Of the 122 patients who demonstrated ischaemia on SE, 112 (92%) underwent coronary arteriography. CAD was demonstrated in 105 (93%) patients, of which 61 (54%) were single vessel and 44 (39%) were multivessel. Eighty-four (75%) proceeded to revascularization. Only three patients with negative SE had coronary angiography and none required revascularization. In the exercise cohort group, 67 of the 74 patients (91%) with ischaemia underwent coronary arteriography. CAD was demonstrated in 60 (90%) patients, of which 42 (70%) had single-vessel disease and 18 (30%) had multivessel disease. Of these, 40 (67%) patients underwent revascularization. Predictors of death or acute myocardial infarction Table 4 shows the univariable and multivariable predictors of hard cardiac events. Clinical univariable predictors include diabetes mellitus (P ¼ 0.06), hypercholesterolaemia (P ¼ 0.06), and higher Framingham's risk score (P ¼ 0.025). Stress ECG univariable predictors include stress heart rate (P ¼ 0.019) and stress ST-T abnormalities (P ¼ 0.044). SE predictors were SWTSI (P , 0.0001) and ischaemic burden (P , 0.0001). Multivariable analysis showed that ischaemic burden was the only independent predictor of hard cardiac events (P , 0.0001). SWTSI showed co-linearity with ischaemic burden and hence was not included in the multivariate model. Table 5 shows the univariable and multivariable predictors of hard cardiac events in the exercise echo cohort. Ischaemic burden was similarly the only independent predictor of hard cardiac events (P , 0.0001).
Fourteen per cent of the patients had resting ST-T changes including LBBB. These patients have been included in our analysis as resting ECG abnormalities are shown to predict outcome. Analysis excluding patients with an abnormal resting ECG did not alter the data. Figure 1 shows the Kaplan -Meier survival curve for patients with and without an ischaemic burden. The calculated mortality rate in 1 year for ischaemic SE was 7%, whereas the calculated mortality rate for a negative SE in 1 year was 0.05%. Figure 2 shows the Kaplan-Meier survival curve for patients with no ischaemic, mild ischaemic burden ¼ 0.5, moderate ischaemic burden ¼ 0.5 -1.5, and severe ischaemic burden . 1.5. Cardiac events increased in a stepwise manner (Figure 3) with increasing ischaemic burden.
Survival analysis

Incremental value of stress echocardiography
A global x 2 model was used to assess the incremental prognostic value of stress ECG (stress ST-T changes) and SE-determined ischaemic burden over standard clinical assessment of risk factors (Framingham's score) in the whole group and the exercise group ( Figure 4A and B) . In both groups, the addition of stress ST-T changes to standard clinical risk stratification did not provide any incremental prognostic information. However, the addition of ischaemia by SE to the model significantly increased the predictive value (P , 0.0001).
Discussion
This study demonstrated that SE was a powerful predictor of hard cardiac events, independent of historic, clinical, and ECG (rest and stress) data in patients presenting with new-onset suspected angina but without a previous history of CAD. It also showed that SE was incremental to clinical and ECG assessments. In a population where the prevalent hard cardiac event rate was 7% over a median follow-up period of 2.5 years, a negative SE predicted an event rate of only 0.25%. This increased to more than three-fold compared with prevalent cardiac event rate when SE demonstrated ischaemia. An increase in ischaemic burden resulted in increased cardiac event in a dose-dependent manner. Furthermore, a positive SE resulted in coronary arteriography in 90% of the patients, of which three quarters underwent revascularization. On the other hand, a negative SE resulted in coronary arteriography in only 0.8% of the patients and none underwent revascularization. These results were replicated in patients undergoing exercise echocardiography. The study also showed that clinical assessment in terms of clinical risk scoring only marginally predicted cardiac events. Stress ECG data did not provide any incremental information, even though majority of the patients (.80%) had a normal resting ECG. This was true also for exercise ECG data. Analysis excluding patients with an abnormal resting ECG did not alter the data. The prevalent practice today for the assessment of new-onset suspected angina is to determine the pre-test probability of CAD. If the probability is intermediate, the patient undergoes stress ECG. The European Society of Cardiology (ESC) guidelines for the assessment of stable angina recommend exercise ECG as the first-line investigation in patients unless they are unable to exercise or have uninterpretable ECG. 19 The practice of initial testing using ECG is recently challenged in a study which showed that stress ECG data provided no incremental prognostic information compared with clinical assessment. 5 ECG changes appear late in the ischaemic cascade. 20, 21 At least 40% of patients may be unable to exercise adequately to provoke ECG changes. 22 This will result in CAD being missed. On the other hand, provocable ischaemic ECG changes may occur in women, with hyperventilation, in hypertensives, diabetics, and in patients with LVH in the absence of CAD. 23 This compromises the prognostic power of exercise ECG. The present study and others support the view that stress ECG is suboptimal for risk stratification in the cohort of patients selected in this study. 5, 24, 25 SE which identifies wall thickening abnormalities is both a sensitive and a specific marker of myocardial ischaemia. 26 -28 Several studies have demonstrated its superior accuracy compared with exercise ECG for the detection and risk stratification of CAD. 13,29 -31 However, there are no large studies that specifically addressed its prognostic value for predicting hard cardiac events in patients with new-onset suspected angina but without a previously documented history of CAD vis-à-vis clinical assessment and stress ECG. The study clearly demonstrated that SE provides important prognostic information beyond that provided by clinical and ECG data. The advent of harmonic imaging and contrast echocardiography has resulted in improved image quality and accuracy for the detection of CAD compared with SE with suboptimal images. A previous prospective randomized controlled trial from our centre has shown that SE with a state-of-the-art technology provides not only improved risk stratification but also has superior cost-profile compared with exercise ECG in patients presenting with suspected acute coronary syndrome. 22 
Comparison with other competing imaging modalities
Large studies have shown that SE is equivalent to radionuclide perfusion imaging for the risk stratification of patients with suspected and known CAD. 32 -34 However, SE is a bedside technique without radiation and is more cost effective than radionuclide perfusion imaging in low-intermediate risk groups. 35 The population in the present study belong primarily to this group. Cardiac magnetic resonance (CMR) imaging provides high-quality wall thickening data, but in patients with good-quality SE images, CMR provides equivalent diagnostic information. 36 However, CMR is more expensive, less readily available, and is less feasible compared with SE. Multidetector cardiac computed tomography (MDCT) images of the coronary arteries are a recent non-invasive technique that has an excellent diagnostic and prognostic value. 37 However, when patients present with chest pain, the question that clinicians need answered is whether the chest pain is due to myocardial ischaemia. This is best answered by functional testing which assesses ischaemia. In the present study, inducible ischaemia detected by SE resulted in 75% of the patients undergoing revascularization, whereas the absence of ischaemia showed excellent prognosis. In a recent study with MDCT, 25% of patients underwent further functional testing because of uncertainty regarding the coronary stenoses. 38 In a large multicentre study, the feasibility of MDCT was only 66%. 39 Thus, additional functional testing, lower feasibility, higher cost, lesser availability, and higher radiation burden compared with SE makes the latter a more attractive technique for the initial evaluation of chest pain.
Clinical implication
The study suggest that in patients presenting with new-onset suspected angina, and after clinical evaluation, those with intermediate risk should undergo an SE rather than exercise ECG as the firstline investigation. A patient with a negative SE does not need further evaluation, whereas those demonstrating significant ischaemia should undergo coronary arteriography with a view to revascularization.
Study limitations
The decision to perform coronary revascularization in patients with a positive SE could have reduced the prognostic power of ischaemia during the tests. However, despite this, the cardiac event rate was high. Furthermore, the decision-making based on the SE result may have biased against stress ECG. We evaluated the entire cohort without breakdown into pre-test subgroups as the aim of the study was to assess the prognostic value of the test in patients referred for functional testing with new-onset symptoms without a prior history of CAD. Therefore, our population should be similar to other hospitals with respect to patient demographics and risk factors and hence can be generalized to the population at other centres. Another limitation of the study is that it is retrospective and therefore, for example, chest pain characteristics were evaluated through questionnaires. However, case notes were also reviewed.
Conclusion
Ischaemic burden determined by SE is an independent predictor of hard cardiac events in patients with new-onset suspected angina and no prior history of CAD. It also provides incremental prognostic value to current standard assessment methods in such patients. SE in this cohort is safe, rapid, and provides accurate risk stratification. 
